PETS logo

PETMED EXPRESS INC

PETSNASDAQ
๐Ÿ† #4562 by market capEarnings Feb 4US Equity
$0.85โ–ผ $0.07 (โˆ’8.04%)
Market closed ยท at close
๐Ÿ””
Track PETS
Get earnings, price moves & breaking news on Telegram
Track
24hโ–ผ 8.0%
7dโ–ผ 9.6%
14dโ–ผ 29.5%
30dโ–ผ 31.4%
ytdโ–ผ 73.4%
1yโ–ผ 46.9%
๐ŸฆMarket Cap
$18M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
-19.7%
Declining
๐Ÿ“ŠGross Margin
29.2%
Moderate
๐Ÿ’ตFCF Margin
6.4%
Moderate
โš–๏ธP/S Ratio
0.1x
Cheap
Otter Score
โ€”
Insufficient data

Trading Snapshot

Day Range
$0.85 โ€“ $0.87
52-Week Range
$0.85 โ€“ $4.10
Volume (shares)
115,750
Avg Volume (shares)
โ€”
Shares Outstanding
21.7M
Next Earnings
2027-02-04

Fundamentals Snapshot

Annual Revenue
$179M
Last Q Revenue
$36M
P/E Ratio
โ€”
P/S Ratio
0.1x
EPS (TTM)
$-1.39
Dividend Yield
0.14%
Dilution (1yr)
+0.3%
PETS logo

PETMED EXPRESS INC

PETS
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$179Mโ–ผ โˆ’21.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
22.8%โ–ผ โˆ’25.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isnโ€™t profitable yet.
โˆ’$31Mโ–ฒ +1953.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
โˆ’$33Mโ–ฒ +8256.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing ownerโ€™s slice.
21.1Mโ–ฒ +0.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$11Mโ–ผ โˆ’$15M YoY
StockOtter ยท stockotter.space

About PETMED EXPRESS INC

PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.

๐Ÿฆฆ

Otter Score Breakdown

How it's scoredFive components, each rated 1โ€“5โ˜… and equally weighted (20%), averaged to a 0โ€“100 score:๐Ÿ’Ž Quality โ€” gross margin๐Ÿš€ Growth โ€” revenue YoYโš–๏ธ Valuation โ€” P/S ratioโšก Momentum โ€” 30-day price change๐Ÿ’ง Dilution โ€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿ’งDilutionโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Insufficient data
โ€”/100
Analyst data unavailable.

Latest News & Updates

Zacks Investment Researchยท12d ago

PetMed (PETS) Reports Q2 Loss, Lags Revenue Estimates

PetMed (PETS) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.41 per share a year ago.

Seeking Alphaยท12d ago

PetMed Express, Inc. (PETS) Q2 2027 Earnings Call Prepared Remarks Transcript

PetMed Express, Inc. (PETS) Q2 2027 Earnings Call Prepared Remarks Transcript

GlobeNewsWireยท12d ago

PetMedsยฎ Announces Second Quarter Financial Results

DELRAY BEACH, Fla., Nov. 10, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its second quarter ended September 30, 2026.

GlobeNewsWireยท13d ago

PetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital Channels

DELRAY BEACH, Fla., Nov. 09, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced a new partnership with Pet Supermarket to offer pet prescription med

GlobeNewsWireยท26d ago

PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026

DELRAY BEACH, Fla., Oct. 27, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the second quarter fiscal year

GlobeNewsWireยทOct 2

PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

DELRAY BEACH, Fla., Oct. 02, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx (Nasdaq: PETS), today announced that PetMeds recently granted equity awards previously approved by i